$LITS News

Lite Strategy Q3 EPS $(0.66) Down From $(0.39) YoY

Lite Strategy Q2 EPS $(0.82) Down From $(0.40) YoY

On Nov 14, Lite Strategy's Board Approves Justin J. File As Permanent CEO; Justin J. File Continues As CFO And Secretary

Lite Strategy Q1 EPS $(0.12) Up From $(1.20) YoY

Lite Strategy Announces $25M Buyback Plan

Lite Strategy: From Biotech To Litecoin Treasury

Crypto hoarding brings a stock pop for small firms—and in some cases shows patterns of possible insider trading

Biotechs Turn to Digital Coins, Crypto to Boost Stock Prices

MEI Pharma Chooses Not Bitcoin, Not Ethereum, But Litecoin As Treasury Asset

Litecoin Hits Five-Month High Amid ETF Optimism and $100M MEI Pharma Treasury

MEI Pharma (MEIP) Becomes the First and Only Publicly Traded LTC Holder on a National Exchange

GSR Leads $100M Private Placement into Nasdaq-listed MEI Pharma to Launch First Institutional Litecoin Treasury Strategy Alongside Charlie Lee

Litecoin Surges 10%; Will $100M Bet by Nasdaq-Listed Company Fuel a Larger Rally?

MEI Pharma Reports Third Quarter Fiscal Year 2025 Cash Position

MEI Pharma Reports Second Quarter Fiscal Year 2025 Cash Position

GreenWood Investors Year End 2024 Letter

MEI Pharma Reports First Quarter Fiscal Year 2025 Cash Position

MEI Pharma stock jumps 8% on sale of drug asset ME-344

MEI Pharma Reports Fiscal Year End 2024 Cash Position

MEI Pharma confirms continuation of evaluation of strategic alternatives